A wave of alarming headlines has recently reignited the global debate over the long-term safety of e-cigarettes. Reports in major media outlets, citing newly published laboratory and epidemiological papers, have boldly suggested that vaping may cause oral, lung, and bladder cancers. However, independent oncology experts, public health advocates, and tobacco control researchers have quickly raised serious concerns regarding the scientific validity of these claims.
Understanding the actual relationship between vaping and cancer requires looking past sensationalized media coverage. By analyzing the fundamental differences between tobacco combustion and vapor aerosol, examining the severe flaws in recent “vapes-cause-cancer” studies, and reviewing the consensus of leading global health organizations, we can separate scientific fact from fear-driven narratives.
Combustion vs. Aerosolization: The Biological Baseline
To understand why the cancer risks of smoking and vaping differ so fundamentally, we must look at how nicotine is delivered. When a traditional cigarette is lit, it undergoes combustion. This burning process reaches temperatures of up to 900°C, creating tobacco smoke that contains a toxic cocktail of over 7,000 chemicals. Among these, at least 70 are confirmed carcinogens, which Cancer Research UK confirms directly damage cellular DNA, leading to the uncontrolled genetic mutations that cause cancer.
Because these toxins enter the bloodstream, smoking causes cancer almost anywhere in the body, including the lungs, mouth, throat, esophagus, stomach, liver, pancreas, kidneys, and bladder.
In contrast, e-cigarettes do not contain tobacco and do not rely on combustion. Instead, they use an electrical element to heat an e-liquid – typically composed of propylene glycol (PG), vegetable glycerin (VG), flavorings, and nicotine – into an aerosol. Because there is no burning, the vast majority of the highly carcinogenic compounds found in tobacco smoke are entirely absent.
Where toxic chemicals are detected in vapor, they are consistently found at trace levels that are far below established safety thresholds. A review by Public Health England estimated that vaping is “around 95 percent less harmful” than smoking, noting that chemical exposure is often comparable to the levels found in medically approved nicotine replacement therapies (NRTs) like patches and gums.
Deconstructing Recent Vaping-Cancer Studies
Despite this clear biological difference, several studies have attempted to establish a direct link between vaping and cancer. However, independent peer reviews of these papers have revealed systemic methodological flaws, ranging from unrealistic laboratory setups to fatal epidemiological errors.
1. The Epigenetic “Cheek Cell” Study (Herzog et al.)
A widely publicized study published in Cancer Research analyzed the “DNA methylation footprint” (epigenetic changes) in the cheek cells of smokers and vapers. Media outlets quickly reported that vaping causes “similar” DNA damage to smoking, implying a shared cancer risk.
However, independent experts urged caution. In a response published by Cancer Research UK, Dr. Julie Sharp, Head of Health Information, pointed out that the study could not confirm whether the observed cell changes were actually caused by vaping, as many of the vapers in the study were former smokers. Decades of prior smoking leave a lasting genetic signature that cannot be easily separated from current vaping habits.
Furthermore, in an expert reaction compiled by the Science Media Centre (SMC), Associate Professor George Laking, Director of the University of Auckland’s Centre for Cancer Research, warned against the misleading use of the word “similar.” He noted that while some epigenetic changes overlapped, smokers exhibited a vast array of severe cellular changes that were completely absent in both vapers and non-smokers. “A lethal snake is in some ways ‘similar’ to a harmless earthworm,” Laking noted, highlighting how the term was used to exaggerate risk.
2. The Systematic Review Retraction (Journal of Cancer Policy)
In early 2026, the Journal of Cancer Policy formally retracted a high-profile systematic review that claimed e-cigarette use was associated with an increased risk of cervical and breast cancers. The retraction notice cited “multiple serious flaws that materially affect the reliability of the findings.”
Behavioral scientist Dr. Arielle Selya explained that the authors committed severe, undisclosed protocol deviations. While they initially registered a plan to review only human clinical outcomes, they later expanded their search to include animal studies, non-peer-reviewed conference abstracts, and data heavily confounded by smoking.
According to a published scientific criticism of the paper, the authors even included and highly rated a study that had already been retracted. This led Smoke Free Sweden to issue a warning about how quickly flawed science can spread misinformation before a retraction occurs.
3. The Early-Onset Lung Cancer Study and “Reverse Causation”
Another paper published in Frontiers in Oncology claimed that dual users (people who both smoke and vape) had a lung cancer risk 2.8 times higher than those who only smoked.
Dr. Michael Siegel, a professor of public health at the Tufts University School of Medicine, criticized this study on his tobacco analysis blog, identifying a fatal flaw: reverse causation. The researchers recorded patients’ vaping habits at the time of their cancer diagnosis but failed to establish a timeline of how long they had vaped before developing symptoms.
Because lung cancer takes decades to develop, it is biologically impossible for recent vaping to have caused the disease. Instead, smokers who develop early symptoms of lung cancer (such as chronic coughing or shortness of breath) often turn to vaping in a desperate attempt to quit smoking. As detailed in studies on reverse directionality, the study blamed vaping for the cancer, when in reality, the early stages of cancer had prompted the vaping. Furthermore, this study also relied on a previously retracted paper to support its claims.
4. The Australian Carcinogenicity Review (Stewart et al.)
Published in Carcinogenesis, a qualitative risk assessment claimed that “cancer is on the horizon for those who vape” due to the detection of biomarkers of harm. This study generated sensationalized headlines in outlets like the Daily Mail, the Australian Broadcasting Corporation, The Independent, and the Los Angeles Times, with the lead author releasing a YouTube video and an EurekAlert press release calling it a “definitive determination.”
However, independent scientists rushed to publish a detailed critique via the Science Media Centre. Dr. Peter Hajek, a professor of clinical psychology at Queen Mary University of London, explained that modern, highly sensitive testing equipment can detect trace amounts of chemicals in almost anything we eat, drink, or inhale. Detecting a chemical does not mean it exists in a quantity capable of causing harm.
Hajek also noted that many of the high chemical levels cited in the review came from laboratory studies that deliberately overheated e-liquid to the point of “dry puffs”—conditions that produce an acrid, unvapeable taste that no human user could tolerate.
Summary of Disputed Vaping-Cancer Studies
The table below summarizes the key studies that have recently attempted to link vaping to cancer, along with the critical scientific rebuttals and methodological flaws identified by independent experts.
| Study & Journal | Core Claim / Headline | Methodological Flaws & Expert Rebuttals |
|---|---|---|
| Herzog et al. Cancer Research | Vaping causes similar DNA damage (methylation) in cheek cells to smoking. | Confounding History: Failed to isolate the lingering genetic effects of past smoking in participants.Misleading Comparisons: Ignored major, severe cellular changes unique to smokers that were absent in vapers. |
| Systematic Review Journal of Cancer Policy (Retracted) | Vaping is linked to an increased risk of breast and cervical cancers. | Protocol Deviations: Quietly changed search criteria to include low-quality animal and biomarker data.Inclusion of Retracted Data: Relied on previously discredited and retracted papers to draw conclusions. |
| Case-Control Study Frontiers in Oncology | Dual users have a 2.8x higher risk of lung cancer than smokers alone. | Reverse Causation: Did not establish a historical timeline. Symptomatic pre-cancerous smokers likely started vaping to quit, meaning the disease preceded the vape use. |
| Stewart et al. Carcinogenesis | Clear cancer pathways exist; vaping is “not safer” than smoking. | No Smoker Comparison: Evaluated vaping in a vacuum without comparing it to combustible tobacco.Extreme Lab Conditions: Relied on “dry puff” data where e-liquids were overheated to unrealistic temperatures. |
StagBar Vape 6in1 180K Puffs Disposable
The Stagbar 6-in-1 featuring a unique 6-flavor system and six independent mesh coils, this device allows users to switch between six distinct tastes in one sleek unit, delivering an unprecedented 180,000 puffs.
The Role of Nicotine in Cancer
A common source of confusion is the role of nicotine. Because nicotine is the primary addictive substance in both cigarettes and e-cigarettes, many people mistakenly believe it is the chemical responsible for tobacco-related cancers.
This is scientifically incorrect. Decades of research on Nicotine Replacement Therapies (NRTs), which have been used safely by millions of people for over thirty years, have confirmed that nicotine is not a carcinogen. In 1964, the US Surgeon General’s Report concluded that nicotine does not cause cancer, a position that has been repeatedly reaffirmed by the World Health Organization (WHO) and Cancer Research UK.
While nicotine is highly addictive and can cause temporary increases in heart rate and blood pressure, it does not damage DNA or trigger tumor growth. Blaming nicotine for cancer is equivalent to blaming the delivery vehicle rather than the toxic cargo.
Passive Vaping: Is Second-Hand Vapor Harmful?
Another frequent concern is whether second-hand vapor poses a cancer risk to bystanders. Passive smoking is a well-documented health hazard, causing thousands of lung cancer deaths among non-smokers every year due to the toxic sidestream smoke that bypasses the smoker’s lungs.
Passive vaping, however, is fundamentally different. Because e-cigarettes do not burn tobacco, there is no toxic “sidestream” smoke. The only vapor released into the air is the exhaled aerosol, which evaporates rapidly.
Air quality studies conducted in confined spaces and at vaping events show that the levels of nicotine and other chemicals in exhaled vapor are negligible. While long-term studies are ongoing, current evidence indicates that second-hand vapor poses no meaningful health or oncological risk to bystanders.
The Public Health Danger of Sensationalized Reporting
The dissemination of flawed scientific papers and sensationalized media coverage has real-world consequences. The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has warned that anti-vaping misinformation directly threatens public health by paralyzing smokers with fear.
When smokers are led to believe that vaping is just as dangerous as smoking, they are highly unlikely to make the switch. Even worse, misled vapers may relapse to combustible cigarettes under the false impression that they are not reducing their health risks.
Nancy Loucas, Executive Coordinator of CAPHRA, emphasizes that responsible health journalism must prioritize relative risk: “If media coverage magnifies the scare but minimizes the scientific objections, people are left with a distorted picture of risk.” Countries that have embraced pragmatic, evidence-based harm reduction policies – such as the United Kingdom and New Zealand – have seen their national smoking rates drop to historic lows. These successes demonstrate that public health policy must be guided by objective facts rather than sensationalized headlines.
StagBar Vape 4in1 80K Puffs Disposable
The Stagbar 4-in-1 80,000 is a revolutionary high-capacity disposable featuring 4 flavors and 4 independent mesh coils in one device, delivering an industry-leading 80,000 puffs.
Frequently Asked Questions
Does nicotine in e-cigarettes cause cancer?
No. Nicotine is an addictive stimulant, but it is not a carcinogen. The cancer risks associated with smoking come from the combustion of tobacco, which releases thousands of toxic chemicals and tar. Nicotine has been used safely for decades in medical stop-smoking aids like patches, gums, and inhalers.
Why do some studies claim vaping causes DNA damage similar to smoking?
Many of these studies suffer from severe methodological errors. They often test cells in laboratory dishes or animals exposed to extreme, unrealistic doses of vapor that do not mimic human use. Additionally, human studies frequently fail to account for the participants’ past smoking histories, meaning the observed DNA damage was likely caused by years of prior cigarette use rather than vaping.
What is “reverse causation” in vaping health studies?
Reverse causation occurs when a study incorrectly identifies the cause and effect. For example, a study might find that people who vape are more likely to be diagnosed with lung cancer. However, if those individuals started vaping because they were already experiencing early, undiagnosed symptoms of lung cancer (such as a chronic cough) and wanted to quit smoking, the cancer actually caused the vaping, not the other way around.
Is second-hand vapor from e-cigarettes harmful to bystanders?
There is currently no scientific evidence showing that second-hand vapor is harmful. Unlike passive smoking, which involves inhaling highly toxic sidestream smoke from burning tobacco, exhaled vape aerosol contains only trace amounts of nicotine and quickly dissipates in the air, posing negligible risk to bystanders.
Why was a major systematic review linking vaping to cancer retracted?
The study, published in the Journal of Cancer Policy, was retracted in early 2026 after independent researchers exposed severe flaws. The authors deviated from their pre-registered scientific protocol, relied on low-quality animal data, ignored smoking histories, and even included a previously retracted paper as “high-quality” evidence to support their claims.
Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, or prevent any health condition. Always consult with a qualified healthcare professional or doctor before making decisions about your health, smoking cessation, or nicotine use.
